2024 Q2 Form 10-Q Financial Statement
#000162828024017536 Filed on April 24, 2024
Income Statement
| Concept | 2024 Q2 | 2024 Q1 | 2023 Q2 |
|---|---|---|---|
| Revenue | $145.4M | $106.4M | $246.8M |
| YoY Change | -41.1% | 5.55% | |
| Cost Of Revenue | $68.78M | $51.31M | $92.93M |
| YoY Change | -25.98% | 19.07% | |
| Gross Profit | $76.58M | $55.07M | $153.9M |
| YoY Change | -50.23% | -1.23% | |
| Gross Profit Margin | 52.68% | 51.77% | 62.35% |
| Selling, General & Admin | $38.70M | $33.55M | $44.89M |
| YoY Change | -13.8% | 0.55% | |
| % of Gross Profit | 50.53% | 60.93% | 29.18% |
| Research & Development | $85.91M | $80.65M | $89.40M |
| YoY Change | -3.9% | 15.29% | |
| % of Gross Profit | 112.18% | 146.45% | 58.1% |
| Depreciation & Amortization | $12.60M | $12.71M | $6.235M |
| YoY Change | 102.07% | 20.93% | |
| % of Gross Profit | 16.45% | 23.09% | 4.05% |
| Operating Expenses | $124.6M | $114.2M | $134.3M |
| YoY Change | -7.21% | 9.9% | |
| Operating Profit | -$48.02M | -$59.13M | $19.57M |
| YoY Change | -345.34% | -41.72% | |
| Interest Expense | $2.527M | $2.223M | $1.656M |
| YoY Change | 52.6% | -1.43% | |
| % of Operating Profit | 8.46% | ||
| Other Income/Expense, Net | |||
| YoY Change | |||
| Pretax Income | -$45.49M | -$56.91M | $22.75M |
| YoY Change | -299.95% | -31.88% | |
| Income Tax | $36.70M | -$385.0K | $7.800M |
| % Of Pretax Income | 34.28% | ||
| Net Earnings | -$82.16M | -$56.53M | $13.97M |
| YoY Change | -688.22% | -39.03% | |
| Net Earnings / Revenue | -56.52% | -53.14% | 5.66% |
| Basic Earnings Per Share | -$2.56 | -$1.77 | $0.44 |
| Diluted Earnings Per Share | -$2.56 | -$1.77 | $0.41 |
| COMMON SHARES | |||
| Basic Shares Outstanding | 31.92M shares | 31.90M | 31.96M |
| Diluted Shares Outstanding | 32.12M shares | 31.91M shares | 33.75M |
Balance Sheet
| Concept | 2024 Q2 | 2024 Q1 | 2023 Q2 |
|---|---|---|---|
| SHORT-TERM ASSETS | |||
| Cash & Short-Term Investments | $339.2M | $332.7M | $1.152B |
| YoY Change | -70.56% | -40.42% | |
| Cash & Equivalents | $240.8M | $191.5M | $716.4M |
| Short-Term Investments | $98.34M | $141.2M | $435.7M |
| Other Short-Term Assets | $53.59M | $82.61M | $87.73M |
| YoY Change | -38.92% | 59.71% | |
| Inventory | $166.1M | $198.2M | $133.2M |
| Prepaid Expenses | |||
| Receivables | $41.21M | $32.62M | $87.69M |
| Other Receivables | $0.00 | $0.00 | $0.00 |
| Total Short-Term Assets | $600.0M | $646.1M | $1.461B |
| YoY Change | -58.92% | -31.21% | |
| LONG-TERM ASSETS | |||
| Property, Plant & Equipment | $139.4M | $142.2M | $152.1M |
| YoY Change | -8.36% | 2.82% | |
| Goodwill | $376.4M | $376.4M | $376.4M |
| YoY Change | 0.0% | 0.0% | |
| Intangibles | $47.37M | $53.45M | $78.40M |
| YoY Change | -39.57% | -27.83% | |
| Long-Term Investments | |||
| YoY Change | |||
| Other Assets | $86.78M | $126.0M | $93.81M |
| YoY Change | -7.49% | 7.33% | |
| Total Long-Term Assets | $649.9M | $698.0M | $700.7M |
| YoY Change | -7.25% | -2.73% | |
| TOTAL ASSETS | |||
| Total Short-Term Assets | $600.0M | $646.1M | $1.461B |
| Total Long-Term Assets | $649.9M | $698.0M | $700.7M |
| Total Assets | $1.250B | $1.344B | $2.161B |
| YoY Change | -42.17% | -23.99% | |
| SHORT-TERM LIABILITIES | |||
| YoY Change | |||
| Accounts Payable | $39.30M | $44.58M | $71.44M |
| YoY Change | -44.99% | 10.95% | |
| Accrued Expenses | |||
| YoY Change | |||
| Deferred Revenue | |||
| YoY Change | |||
| Short-Term Debt | $0.00 | $0.00 | $0.00 |
| YoY Change | |||
| Long-Term Debt Due | $530.1M | ||
| YoY Change | |||
| Total Short-Term Liabilities | $100.1M | $111.4M | $693.3M |
| YoY Change | -85.56% | 181.6% | |
| LONG-TERM LIABILITIES | |||
| Long-Term Debt | $0.00 | $0.00 | $0.00 |
| YoY Change | -100.0% | ||
| Other Long-Term Liabilities | $56.85M | $67.23M | $48.66M |
| YoY Change | 16.81% | -21.27% | |
| Total Long-Term Liabilities | $56.85M | $67.23M | $48.66M |
| YoY Change | 16.81% | -21.27% | |
| TOTAL LIABILITIES | |||
| Total Short-Term Liabilities | $100.1M | $111.4M | $693.3M |
| Total Long-Term Liabilities | $56.85M | $67.23M | $48.66M |
| Total Liabilities | $157.0M | $178.6M | $742.0M |
| YoY Change | -78.85% | -11.26% | |
| SHAREHOLDERS EQUITY | |||
| Retained Earnings | $1.054B | $1.136B | $1.426B |
| YoY Change | -26.08% | -29.34% | |
| Common Stock | $3.000K | $3.000K | $3.000K |
| YoY Change | 0.0% | -25.0% | |
| Preferred Stock | |||
| YoY Change | |||
| Treasury Stock (at cost) | |||
| YoY Change | |||
| Treasury Stock Shares | |||
| Shareholders Equity | $1.093B | $1.166B | $1.419B |
| YoY Change | |||
| Total Liabilities & Shareholders Equity | $1.250B | $1.344B | $2.161B |
| YoY Change | -42.17% | -23.99% |
Cashflow Statement
| Concept | 2024 Q2 | 2024 Q1 | 2023 Q2 |
|---|---|---|---|
| OPERATING ACTIVITIES | |||
| Net Income | -$82.16M | -$56.53M | $13.97M |
| YoY Change | -688.22% | -39.03% | |
| Depreciation, Depletion And Amortization | $12.60M | $12.71M | $6.235M |
| YoY Change | 102.07% | 20.93% | |
| Cash From Operating Activities | $16.13M | -$71.80M | -$13.28M |
| YoY Change | -221.49% | -117.66% | |
| INVESTING ACTIVITIES | |||
| Capital Expenditures | $3.530M | $2.047M | $7.657M |
| YoY Change | -53.9% | 68.14% | |
| Acquisitions | |||
| YoY Change | |||
| Other Investing Activities | $43.14M | $83.54M | $261.9M |
| YoY Change | -83.53% | -223.07% | |
| Cash From Investing Activities | $39.61M | $81.49M | $254.3M |
| YoY Change | -84.42% | -216.97% | |
| FINANCING ACTIVITIES | |||
| Cash Dividend Paid | |||
| YoY Change | |||
| Common Stock Issuance & Retirement, Net | $17.61M | ||
| YoY Change | -88.84% | ||
| Debt Paid & Issued, Net | $45.00M | $0.00 | |
| YoY Change | |||
| Cash From Financing Activities | -6.398M | -45.71M | -24.54M |
| YoY Change | -73.93% | -85.26% | |
| NET CHANGE | |||
| Cash From Operating Activities | 16.13M | -71.80M | -13.28M |
| Cash From Investing Activities | 39.61M | 81.49M | 254.3M |
| Cash From Financing Activities | -6.398M | -45.71M | -24.54M |
| Net Change In Cash | 49.35M | -36.02M | 216.5M |
| YoY Change | -77.2% | -170.12% | |
| FREE CASH FLOW | |||
| Cash From Operating Activities | $16.13M | -$71.80M | -$13.28M |
| Capital Expenditures | $3.530M | $2.047M | $7.657M |
| Free Cash Flow | $12.60M | -$73.85M | -$20.94M |
| YoY Change | -160.2% | -129.63% |
Facts In Submission
| Frame | Concept Type | Concept / XBRL Key | Value | Unit |
|---|---|---|---|---|
| CY2023Q4 | us-gaap |
Common Stock Shares Outstanding
CommonStockSharesOutstanding
|
31897000 | shares |
| CY2023Q4 | us-gaap |
Common Stock Shares Issued
CommonStockSharesIssued
|
31897000 | shares |
| CY2024Q1 | us-gaap |
Cost Of Revenue
CostOfRevenue
|
51306000 | usd |
| CY2023Q2 | us-gaap |
Cost Of Revenue
CostOfRevenue
|
92927000 | usd |
| CY2024Q1 | us-gaap |
Gross Profit
GrossProfit
|
55069000 | usd |
| CY2023Q2 | us-gaap |
Gross Profit
GrossProfit
|
153860000 | usd |
| CY2024Q1 | us-gaap |
Research And Development Expense
ResearchAndDevelopmentExpense
|
80650000 | usd |
| CY2023Q2 | us-gaap |
Research And Development Expense
ResearchAndDevelopmentExpense
|
89396000 | usd |
| CY2024Q1 | us-gaap |
Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
|
33553000 | usd |
| CY2023Q2 | us-gaap |
Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
|
44891000 | usd |
| CY2024Q1 | us-gaap |
Operating Expenses
OperatingExpenses
|
114203000 | usd |
| CY2023Q2 | us-gaap |
Operating Expenses
OperatingExpenses
|
134287000 | usd |
| CY2024Q1 | us-gaap |
Operating Income Loss
OperatingIncomeLoss
|
-59134000 | usd |
| CY2023Q2 | us-gaap |
Operating Income Loss
OperatingIncomeLoss
|
19573000 | usd |
| CY2024Q1 | us-gaap |
Investment Income Nonoperating
InvestmentIncomeNonoperating
|
2732000 | usd |
| CY2023Q2 | us-gaap |
Investment Income Nonoperating
InvestmentIncomeNonoperating
|
4836000 | usd |
| CY2024Q1 | us-gaap |
Interest Expense
InterestExpense
|
509000 | usd |
| CY2023Q2 | us-gaap |
Interest Expense
InterestExpense
|
1656000 | usd |
| CY2024Q1 | us-gaap |
Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments
IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments
|
-56911000 | usd |
| CY2023Q2 | us-gaap |
Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments
IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments
|
22753000 | usd |
| CY2024Q1 | us-gaap |
Income Tax Expense Benefit
IncomeTaxExpenseBenefit
|
-385000 | usd |
| CY2023Q2 | us-gaap |
Income Tax Expense Benefit
IncomeTaxExpenseBenefit
|
7753000 | usd |
| CY2024Q1 | us-gaap |
Income Loss From Equity Method Investments
IncomeLossFromEquityMethodInvestments
|
0 | usd |
| CY2023Q2 | us-gaap |
Income Loss From Equity Method Investments
IncomeLossFromEquityMethodInvestments
|
-1033000 | usd |
| CY2024Q1 | us-gaap |
Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
|
-56526000 | usd |
| CY2023Q2 | us-gaap |
Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
|
13967000 | usd |
| CY2024Q1 | us-gaap |
Earnings Per Share Basic
EarningsPerShareBasic
|
-1.77 | |
| CY2023Q2 | us-gaap |
Earnings Per Share Basic
EarningsPerShareBasic
|
0.44 | |
| CY2024Q1 | us-gaap |
Earnings Per Share Diluted
EarningsPerShareDiluted
|
-1.77 | |
| CY2023Q2 | us-gaap |
Earnings Per Share Diluted
EarningsPerShareDiluted
|
0.41 | |
| CY2024Q1 | us-gaap |
Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
|
31910000 | shares |
| CY2023Q2 | us-gaap |
Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
|
31959000 | shares |
| CY2024Q1 | us-gaap |
Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
|
31910000 | shares |
| CY2023Q2 | us-gaap |
Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
|
33753000 | shares |
| CY2024Q1 | us-gaap |
Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
|
-56526000 | usd |
| CY2023Q2 | us-gaap |
Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
|
13967000 | usd |
| CY2024Q1 | us-gaap |
Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Before Tax
OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodBeforeTax
|
624000 | usd |
| CY2023Q2 | us-gaap |
Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Before Tax
OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodBeforeTax
|
2997000 | usd |
| CY2024Q1 | us-gaap |
Other Comprehensive Income Loss Reclassification Adjustment From Aoci For Sale Of Securities Before Tax
OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIForSaleOfSecuritiesBeforeTax
|
-15000 | usd |
| CY2023Q2 | us-gaap |
Other Comprehensive Income Loss Reclassification Adjustment From Aoci For Sale Of Securities Before Tax
OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIForSaleOfSecuritiesBeforeTax
|
-2614000 | usd |
| CY2024Q1 | us-gaap |
Other Comprehensive Income Loss Cash Flow Hedge Gain Loss Before Reclassification And Tax
OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAndTax
|
275000 | usd |
| CY2023Q2 | us-gaap |
Other Comprehensive Income Loss Cash Flow Hedge Gain Loss Before Reclassification And Tax
OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAndTax
|
38000 | usd |
| CY2024Q1 | us-gaap |
Other Comprehensive Income Loss Cash Flow Hedge Gain Loss Reclassification Before Tax
OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationBeforeTax
|
234000 | usd |
| CY2023Q2 | us-gaap |
Other Comprehensive Income Loss Cash Flow Hedge Gain Loss Reclassification Before Tax
OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationBeforeTax
|
30000 | usd |
| CY2024Q1 | us-gaap |
Other Comprehensive Income Loss Before Tax Portion Attributable To Parent
OtherComprehensiveIncomeLossBeforeTaxPortionAttributableToParent
|
679000 | usd |
| CY2023Q2 | us-gaap |
Other Comprehensive Income Loss Before Tax Portion Attributable To Parent
OtherComprehensiveIncomeLossBeforeTaxPortionAttributableToParent
|
5619000 | usd |
| CY2024Q1 | us-gaap |
Other Comprehensive Income Loss Tax Portion Attributable To Parent1
OtherComprehensiveIncomeLossTaxPortionAttributableToParent1
|
131000 | usd |
| CY2023Q2 | us-gaap |
Other Comprehensive Income Loss Tax Portion Attributable To Parent1
OtherComprehensiveIncomeLossTaxPortionAttributableToParent1
|
1394000 | usd |
| CY2024Q1 | us-gaap |
Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
|
548000 | usd |
| CY2023Q2 | us-gaap |
Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
|
4225000 | usd |
| CY2024Q1 | us-gaap |
Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
|
-55978000 | usd |
| CY2023Q2 | us-gaap |
Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
|
18192000 | usd |
| CY2023Q4 | us-gaap |
Stockholders Equity
StockholdersEquity
|
1208682000 | usd |
| CY2024Q1 | us-gaap |
Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
|
-56526000 | usd |
| CY2024Q1 | us-gaap |
Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
|
548000 | usd |
| CY2024Q1 | us-gaap |
Stock Issued During Period Value Share Based Compensation
StockIssuedDuringPeriodValueShareBasedCompensation
|
-707000 | usd |
| CY2024Q1 | us-gaap |
Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
|
13564000 | usd |
| CY2024Q1 | us-gaap |
Stockholders Equity
StockholdersEquity
|
1165561000 | usd |
| CY2022Q4 | us-gaap |
Stockholders Equity
StockholdersEquity
|
1405008000 | usd |
| CY2023Q2 | us-gaap |
Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
|
13967000 | usd |
| CY2023Q2 | us-gaap |
Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
|
4225000 | usd |
| CY2023Q2 | us-gaap |
Stock Issued During Period Value Share Based Compensation
StockIssuedDuringPeriodValueShareBasedCompensation
|
-6931000 | usd |
| CY2023Q2 | us-gaap |
Stock Repurchased During Period Value
StockRepurchasedDuringPeriodValue
|
13478000 | usd |
| CY2023Q2 | us-gaap |
Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
|
16663000 | usd |
| CY2023Q2 | us-gaap |
Stockholders Equity
StockholdersEquity
|
1419454000 | usd |
| CY2024Q1 | us-gaap |
Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
|
-56526000 | usd |
| CY2023Q2 | us-gaap |
Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
|
13967000 | usd |
| CY2024Q1 | us-gaap |
Depreciation
Depreciation
|
6634000 | usd |
| CY2023Q2 | us-gaap |
Depreciation
Depreciation
|
6235000 | usd |
| CY2024Q1 | slab |
Amortization Of Intangibles And Other Assets
AmortizationOfIntangiblesAndOtherAssets
|
6079000 | usd |
| CY2023Q2 | slab |
Amortization Of Intangibles And Other Assets
AmortizationOfIntangiblesAndOtherAssets
|
6510000 | usd |
| CY2024Q1 | us-gaap |
Amortization Of Financing Costs And Discounts
AmortizationOfFinancingCostsAndDiscounts
|
0 | usd |
| CY2023Q2 | us-gaap |
Amortization Of Financing Costs And Discounts
AmortizationOfFinancingCostsAndDiscounts
|
523000 | usd |
| CY2024Q1 | us-gaap |
Share Based Compensation
ShareBasedCompensation
|
13612000 | usd |
| CY2023Q2 | us-gaap |
Share Based Compensation
ShareBasedCompensation
|
16638000 | usd |
| CY2024Q1 | us-gaap |
Income Loss From Equity Method Investments
IncomeLossFromEquityMethodInvestments
|
0 | usd |
| CY2023Q2 | us-gaap |
Income Loss From Equity Method Investments
IncomeLossFromEquityMethodInvestments
|
-1033000 | usd |
| CY2024Q1 | us-gaap |
Deferred Income Taxes And Tax Credits
DeferredIncomeTaxesAndTaxCredits
|
-5270000 | usd |
| CY2023Q2 | us-gaap |
Deferred Income Taxes And Tax Credits
DeferredIncomeTaxesAndTaxCredits
|
-2670000 | usd |
| CY2024Q1 | us-gaap |
Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
|
3321000 | usd |
| CY2023Q2 | us-gaap |
Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
|
16257000 | usd |
| CY2024Q1 | us-gaap |
Increase Decrease In Inventories
IncreaseDecreaseInInventories
|
3958000 | usd |
| CY2023Q2 | us-gaap |
Increase Decrease In Inventories
IncreaseDecreaseInInventories
|
32794000 | usd |
| CY2024Q1 | us-gaap |
Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
|
15466000 | usd |
| CY2023Q2 | us-gaap |
Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
|
-11530000 | usd |
| CY2024Q1 | us-gaap |
Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
|
-13829000 | usd |
| CY2023Q2 | us-gaap |
Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
|
-12966000 | usd |
| CY2024Q1 | slab |
Increase Decrease In Other Current Liabilities And Income Taxes
IncreaseDecreaseInOtherCurrentLiabilitiesAndIncomeTaxes
|
1554000 | usd |
| CY2023Q2 | slab |
Increase Decrease In Other Current Liabilities And Income Taxes
IncreaseDecreaseInOtherCurrentLiabilitiesAndIncomeTaxes
|
-8529000 | usd |
| CY2024Q1 | slab |
Increase Decrease In Deferred Revenue And Returns Liability
IncreaseDecreaseInDeferredRevenueAndReturnsLiability
|
1804000 | usd |
| CY2023Q2 | slab |
Increase Decrease In Deferred Revenue And Returns Liability
IncreaseDecreaseInDeferredRevenueAndReturnsLiability
|
4478000 | usd |
| CY2024Q1 | us-gaap |
Increase Decrease In Other Noncurrent Liabilities
IncreaseDecreaseInOtherNoncurrentLiabilities
|
-3113000 | usd |
| CY2023Q2 | us-gaap |
Increase Decrease In Other Noncurrent Liabilities
IncreaseDecreaseInOtherNoncurrentLiabilities
|
-978000 | usd |
| CY2024Q1 | us-gaap |
Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
|
-71800000 | usd |
| CY2023Q2 | us-gaap |
Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
|
-13280000 | usd |
| CY2024Q1 | us-gaap |
Payments To Acquire Marketable Securities
PaymentsToAcquireMarketableSecurities
|
9794000 | usd |
| CY2023Q2 | us-gaap |
Payments To Acquire Marketable Securities
PaymentsToAcquireMarketableSecurities
|
66113000 | usd |
| CY2024Q1 | slab |
Proceeds From Sale Of Marketable Securities
ProceedsFromSaleOfMarketableSecurities
|
25763000 | usd |
| CY2023Q2 | slab |
Proceeds From Sale Of Marketable Securities
ProceedsFromSaleOfMarketableSecurities
|
170317000 | usd |
| CY2024Q1 | slab |
Proceeds From Maturity Of Marketable Securities
ProceedsFromMaturityOfMarketableSecurities
|
55188000 | usd |
| CY2023Q2 | slab |
Proceeds From Maturity Of Marketable Securities
ProceedsFromMaturityOfMarketableSecurities
|
157734000 | usd |
| CY2024Q1 | us-gaap |
Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
|
2047000 | usd |
| CY2023Q2 | us-gaap |
Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
|
7657000 | usd |
| CY2024Q1 | us-gaap |
Proceeds From Sale Of Equity Method Investments
ProceedsFromSaleOfEquityMethodInvestments
|
12382000 | usd |
| CY2023Q2 | us-gaap |
Proceeds From Sale Of Equity Method Investments
ProceedsFromSaleOfEquityMethodInvestments
|
0 | usd |
| CY2024Q1 | us-gaap |
Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
|
81492000 | usd |
| CY2023Q2 | us-gaap |
Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
|
254281000 | usd |
| CY2024Q1 | us-gaap |
Repayments Of Long Term Debt
RepaymentsOfLongTermDebt
|
45000000 | usd |
| CY2023Q2 | us-gaap |
Repayments Of Long Term Debt
RepaymentsOfLongTermDebt
|
0 | usd |
| CY2024Q1 | us-gaap |
Payments For Repurchase Of Common Stock
PaymentsForRepurchaseOfCommonStock
|
0 | usd |
| CY2023Q2 | us-gaap |
Payments For Repurchase Of Common Stock
PaymentsForRepurchaseOfCommonStock
|
17608000 | usd |
| CY2024Q1 | us-gaap |
Payments Related To Tax Withholding For Share Based Compensation
PaymentsRelatedToTaxWithholdingForShareBasedCompensation
|
1048000 | usd |
| CY2023Q2 | us-gaap |
Payments Related To Tax Withholding For Share Based Compensation
PaymentsRelatedToTaxWithholdingForShareBasedCompensation
|
6931000 | usd |
| CY2024Q1 | us-gaap |
Proceeds From Issuance Of Common Stock
ProceedsFromIssuanceOfCommonStock
|
341000 | usd |
| CY2023Q2 | us-gaap |
Proceeds From Issuance Of Common Stock
ProceedsFromIssuanceOfCommonStock
|
0 | usd |
| CY2024Q1 | us-gaap |
Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
|
-45707000 | usd |
| CY2023Q2 | us-gaap |
Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
|
-24539000 | usd |
| CY2024Q1 | us-gaap |
Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
|
-36015000 | usd |
| CY2023Q2 | us-gaap |
Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
|
216462000 | usd |
| CY2023Q4 | us-gaap |
Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
|
227504000 | usd |
| CY2022Q4 | us-gaap |
Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
|
499915000 | usd |
| CY2024Q1 | us-gaap |
Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
|
191489000 | usd |
| CY2023Q2 | us-gaap |
Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
|
716377000 | usd |
| CY2024Q1 | us-gaap |
Fiscal Period
FiscalPeriod
|
<div style="margin-top:12pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company prepares financial statements on a 52- or 53-week fiscal year that ends on the Saturday closest to December 30. Fiscal 2024 will have 52 weeks and fiscal 2023 had 52 weeks. In a 52-week year, each fiscal quarter consists of 13 weeks.</span></div> | |
| CY2024Q1 | us-gaap |
Use Of Estimates
UseOfEstimates
|
<div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Use of Estimates</span></div><div style="margin-top:12pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The preparation of financial statements in conformity with U.S. GAAP requires management to make estimates and assumptions that affect the amounts reported in the financial statements and accompanying notes. Among the significant estimates affecting the financial statements are those related to inventories, goodwill, acquired intangible assets, other long-lived assets, revenue recognition, stock-based compensation, and income taxes. Actual results could differ from those estimates, and such differences could be material to the financial statements. The Company periodically reviews the assumptions used in its financial statement estimates.</span></div> | |
| CY2024Q1 | us-gaap |
Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
|
-56526000 | usd |
| CY2023Q2 | us-gaap |
Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
|
13967000 | usd |
| CY2024Q1 | us-gaap |
Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
|
31910000 | shares |
| CY2023Q2 | us-gaap |
Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
|
31959000 | shares |
| CY2024Q1 | slab |
Incremental Common Shares Attributable To Dilutive Effect Of Share Based Payment Arrangements And Conversion Of Debt Securities
IncrementalCommonSharesAttributableToDilutiveEffectOfShareBasedPaymentArrangementsAndConversionOfDebtSecurities
|
0 | shares |
| CY2023Q2 | slab |
Incremental Common Shares Attributable To Dilutive Effect Of Share Based Payment Arrangements And Conversion Of Debt Securities
IncrementalCommonSharesAttributableToDilutiveEffectOfShareBasedPaymentArrangementsAndConversionOfDebtSecurities
|
1794000 | shares |
| CY2024Q1 | slab |
Weighted Average Number Of Shares Outstanding Diluted Shares Used In Calculating Earnings Per Share Continuing Operations
WeightedAverageNumberOfSharesOutstandingDilutedSharesUsedInCalculatingEarningsPerShareContinuingOperations
|
31910000 | shares |
| CY2023Q2 | slab |
Weighted Average Number Of Shares Outstanding Diluted Shares Used In Calculating Earnings Per Share Continuing Operations
WeightedAverageNumberOfSharesOutstandingDilutedSharesUsedInCalculatingEarningsPerShareContinuingOperations
|
33753000 | shares |
| CY2024Q1 | us-gaap |
Earnings Per Share Basic
EarningsPerShareBasic
|
-1.77 | |
| CY2023Q2 | us-gaap |
Earnings Per Share Basic
EarningsPerShareBasic
|
0.44 | |
| CY2024Q1 | us-gaap |
Earnings Per Share Diluted
EarningsPerShareDiluted
|
-1.77 | |
| CY2023Q2 | us-gaap |
Earnings Per Share Diluted
EarningsPerShareDiluted
|
0.41 | |
| CY2024Q1 | slab |
Incremental Common Shares Attributable To Dilutive Effect Of Conversion Of Debt Securities Treasury Stock Method
IncrementalCommonSharesAttributableToDilutiveEffectOfConversionOfDebtSecuritiesTreasuryStockMethod
|
400000 | shares |
| CY2023Q2 | slab |
Incremental Common Shares Attributable To Dilutive Effect Of Conversion Of Debt Securities Treasury Stock Method
IncrementalCommonSharesAttributableToDilutiveEffectOfConversionOfDebtSecuritiesTreasuryStockMethod
|
1200000 | shares |
| CY2024Q1 | us-gaap |
Cash And Cash Equivalents Fair Value Disclosure
CashAndCashEquivalentsFairValueDisclosure
|
107746000 | usd |
| CY2024Q1 | us-gaap |
Short Term Investments
ShortTermInvestments
|
141201000 | usd |
| CY2024Q1 | us-gaap |
Assets Fair Value Disclosure
AssetsFairValueDisclosure
|
248947000 | usd |
| CY2023Q4 | us-gaap |
Cash And Cash Equivalents Fair Value Disclosure
CashAndCashEquivalentsFairValueDisclosure
|
137195000 | usd |
| CY2023Q4 | us-gaap |
Short Term Investments
ShortTermInvestments
|
211720000 | usd |
| CY2023Q4 | us-gaap |
Assets Fair Value Disclosure
AssetsFairValueDisclosure
|
348915000 | usd |
| CY2024Q1 | us-gaap |
Cash Cash Equivalents And Short Term Investments
CashCashEquivalentsAndShortTermInvestments
|
249538000 | usd |
| CY2024Q1 | us-gaap |
Available For Sale Debt Securities Accumulated Gross Unrealized Gain Before Tax
AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax
|
65000 | usd |
| CY2024Q1 | us-gaap |
Available For Sale Debt Securities Accumulated Gross Unrealized Loss Before Tax
AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax
|
656000 | usd |
| CY2024Q1 | slab |
Debt Securities Available For Sale And Cash Equivalents Fair Value
DebtSecuritiesAvailableForSaleAndCashEquivalentsFairValue
|
248947000 | usd |
| CY2024Q1 | us-gaap |
Cash And Cash Equivalents Fair Value Disclosure
CashAndCashEquivalentsFairValueDisclosure
|
107746000 | usd |
| CY2024Q1 | us-gaap |
Available For Sale Securities Debt Securities
AvailableForSaleSecuritiesDebtSecurities
|
141201000 | usd |
| CY2023Q4 | us-gaap |
Cash Cash Equivalents And Short Term Investments
CashCashEquivalentsAndShortTermInvestments
|
350144000 | usd |
| CY2023Q4 | us-gaap |
Available For Sale Debt Securities Accumulated Gross Unrealized Gain Before Tax
AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax
|
206000 | usd |
| CY2023Q4 | us-gaap |
Available For Sale Debt Securities Accumulated Gross Unrealized Loss Before Tax
AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax
|
1435000 | usd |
| CY2023Q4 | slab |
Debt Securities Available For Sale And Cash Equivalents Fair Value
DebtSecuritiesAvailableForSaleAndCashEquivalentsFairValue
|
348915000 | usd |
| CY2023Q4 | us-gaap |
Cash And Cash Equivalents Fair Value Disclosure
CashAndCashEquivalentsFairValueDisclosure
|
137195000 | usd |
| CY2023Q4 | us-gaap |
Available For Sale Securities Debt Securities
AvailableForSaleSecuritiesDebtSecurities
|
211720000 | usd |
| CY2024Q1 | us-gaap |
Available For Sale Securities Debt Maturities Within One Year Amortized Cost
AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearAmortizedCost
|
112498000 | usd |
| CY2024Q1 | us-gaap |
Available For Sale Securities Debt Maturities Within One Year Fair Value
AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearFairValue
|
112010000 | usd |
| CY2024Q1 | us-gaap |
Available For Sale Securities Debt Maturities After One Through Five Years Amortized Cost
AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughFiveYearsAmortizedCost
|
29294000 | usd |
| CY2024Q1 | us-gaap |
Available For Sale Securities Debt Maturities After One Through Five Years Fair Value
AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughFiveYearsFairValue
|
29191000 | usd |
| CY2024Q1 | us-gaap |
Available For Sale Debt Securities Amortized Cost Basis
AvailableForSaleDebtSecuritiesAmortizedCostBasis
|
141792000 | usd |
| CY2024Q1 | us-gaap |
Available For Sale Securities Debt Securities
AvailableForSaleSecuritiesDebtSecurities
|
141201000 | usd |
| CY2024Q1 | us-gaap |
Debt Securities Available For Sale Continuous Unrealized Loss Position Less Than12 Months
DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12Months
|
39143000 | usd |
| CY2024Q1 | us-gaap |
Debt Securities Available For Sale Continuous Unrealized Loss Position Less Than12 Months Accumulated Loss
DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsAccumulatedLoss
|
167000 | usd |
| CY2024Q1 | us-gaap |
Debt Securities Available For Sale Continuous Unrealized Loss Position12 Months Or Longer
DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLonger
|
60497000 | usd |
| CY2024Q1 | us-gaap |
Debt Securities Available For Sale Continuous Unrealized Loss Position12 Months Or Longer Accumulated Loss
DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerAccumulatedLoss
|
489000 | usd |
| CY2024Q1 | us-gaap |
Debt Securities Available For Sale Unrealized Loss Position
DebtSecuritiesAvailableForSaleUnrealizedLossPosition
|
99640000 | usd |
| CY2024Q1 | us-gaap |
Debt Securities Available For Sale Unrealized Loss Position Accumulated Loss
DebtSecuritiesAvailableForSaleUnrealizedLossPositionAccumulatedLoss
|
656000 | usd |
| CY2023Q4 | us-gaap |
Debt Securities Available For Sale Continuous Unrealized Loss Position Less Than12 Months
DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12Months
|
40704000 | usd |
| CY2023Q4 | us-gaap |
Debt Securities Available For Sale Continuous Unrealized Loss Position Less Than12 Months Accumulated Loss
DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsAccumulatedLoss
|
128000 | usd |
| CY2023Q4 | us-gaap |
Debt Securities Available For Sale Continuous Unrealized Loss Position12 Months Or Longer
DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLonger
|
126882000 | usd |
| CY2023Q4 | us-gaap |
Debt Securities Available For Sale Continuous Unrealized Loss Position12 Months Or Longer Accumulated Loss
DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerAccumulatedLoss
|
1307000 | usd |
| CY2023Q4 | us-gaap |
Debt Securities Available For Sale Unrealized Loss Position
DebtSecuritiesAvailableForSaleUnrealizedLossPosition
|
167586000 | usd |
| CY2023Q4 | us-gaap |
Debt Securities Available For Sale Unrealized Loss Position Accumulated Loss
DebtSecuritiesAvailableForSaleUnrealizedLossPositionAccumulatedLoss
|
1435000 | usd |
| CY2024Q1 | us-gaap |
Inventory Work In Process
InventoryWorkInProcess
|
173379000 | usd |
| CY2023Q4 | us-gaap |
Inventory Work In Process
InventoryWorkInProcess
|
173802000 | usd |
| CY2024Q1 | us-gaap |
Inventory Finished Goods
InventoryFinishedGoods
|
24827000 | usd |
| CY2023Q4 | us-gaap |
Inventory Finished Goods
InventoryFinishedGoods
|
20493000 | usd |
| CY2024Q1 | us-gaap |
Inventory Net
InventoryNet
|
198206000 | usd |
| CY2023Q4 | us-gaap |
Inventory Net
InventoryNet
|
194295000 | usd |
| CY2024Q1 | us-gaap |
Operating Lease Lease Income
OperatingLeaseLeaseIncome
|
800000 | usd |
| CY2023Q2 | us-gaap |
Operating Lease Lease Income
OperatingLeaseLeaseIncome
|
700000 | usd |
| CY2024Q1 | slab |
Maximum Cash And Cash Equivalents Used In Calculating Net Leverage Ratio
MaximumCashAndCashEquivalentsUsedInCalculatingNetLeverageRatio
|
750000000 | usd |
| CY2024Q1 | us-gaap |
Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
|
106375000 | usd |
| CY2023Q2 | us-gaap |
Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
|
246787000 | usd |
| CY2024Q1 | us-gaap |
Contract With Customer Performance Obligation Satisfied In Previous Period
ContractWithCustomerPerformanceObligationSatisfiedInPreviousPeriod
|
4200000 | usd |
| CY2023Q2 | us-gaap |
Contract With Customer Performance Obligation Satisfied In Previous Period
ContractWithCustomerPerformanceObligationSatisfiedInPreviousPeriod
|
4900000 | usd |
| CY2024Q1 | us-gaap |
Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
|
106375000 | usd |
| CY2023Q2 | us-gaap |
Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
|
246787000 | usd |
| CY2024Q1 | us-gaap |
Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
|
13612000 | usd |
| CY2023Q2 | us-gaap |
Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
|
16638000 | usd |
| CY2024Q1 | us-gaap |
Employee Service Share Based Compensation Tax Benefit From Compensation Expense
EmployeeServiceShareBasedCompensationTaxBenefitFromCompensationExpense
|
1727000 | usd |
| CY2023Q2 | us-gaap |
Employee Service Share Based Compensation Tax Benefit From Compensation Expense
EmployeeServiceShareBasedCompensationTaxBenefitFromCompensationExpense
|
1786000 | usd |
| CY2024Q1 | us-gaap |
Allocated Share Based Compensation Expense Net Of Tax
AllocatedShareBasedCompensationExpenseNetOfTax
|
11885000 | usd |
| CY2023Q2 | us-gaap |
Allocated Share Based Compensation Expense Net Of Tax
AllocatedShareBasedCompensationExpenseNetOfTax
|
14852000 | usd |
| CY2024Q1 | us-gaap |
Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized
EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized
|
80300000 | usd |
| CY2024Q1 | us-gaap |
Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized Period For Recognition1
EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1
|
P2Y | |
| CY2024Q1 | us-gaap |
Income Tax Expense Benefit
IncomeTaxExpenseBenefit
|
-400000 | usd |
| CY2023Q2 | us-gaap |
Income Tax Expense Benefit
IncomeTaxExpenseBenefit
|
7800000 | usd |
| CY2024Q1 | us-gaap |
Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
|
-0.007 | |
| CY2023Q2 | us-gaap |
Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
|
0.357 | |
| CY2024Q1 | us-gaap |
Unrecognized Tax Benefits
UnrecognizedTaxBenefits
|
5900000 | usd |
| CY2024Q1 | us-gaap |
Unrecognized Tax Benefits That Would Impact Effective Tax Rate
UnrecognizedTaxBenefitsThatWouldImpactEffectiveTaxRate
|
5300000 | usd |
| CY2024Q1 | us-gaap |
Decrease In Unrecognized Tax Benefits Is Reasonably Possible
DecreaseInUnrecognizedTaxBenefitsIsReasonablyPossible
|
1900000 | usd |
| CY2023Q4 | us-gaap |
Restructuring And Related Cost Number Of Positions Eliminated Period Percent
RestructuringAndRelatedCostNumberOfPositionsEliminatedPeriodPercent
|
0.10 | |
| CY2023Q4 | us-gaap |
Restructuring Reserve
RestructuringReserve
|
4400000 | usd |
| CY2024Q1 | us-gaap |
Restructuring Charges
RestructuringCharges
|
500000 | usd |
| CY2024Q1 | us-gaap |
Payments For Restructuring
PaymentsForRestructuring
|
1000000.0 | usd |
| CY2024Q1 | us-gaap |
Restructuring Reserve
RestructuringReserve
|
3900000 | usd |
| CY2024Q1 | us-gaap |
Restructuring Charges
RestructuringCharges
|
500000 | usd |
| CY2024Q1 | ecd |
Non Rule10b51 Arr Adopted Flag
NonRule10b51ArrAdoptedFlag
|
false | |
| CY2024Q1 | ecd |
Non Rule10b51 Arr Trmntd Flag
NonRule10b51ArrTrmntdFlag
|
false |
